BIOMAT Database Logo BIOMAT Database Logo

Continuous infusion of metoclopramide for prevention of chemotherapy-induced emesis. 1986

W A Agostinucci, and R H Gannon, and P K Schauer, and J K Walters

UI MeSH Term Description Entries
D007263 Infusions, Parenteral The administration of liquid medication, nutrient, or other fluid through some other route than the alimentary canal, usually over minutes or hours, either by gravity flow or often by infusion pumping. Intra-Abdominal Infusions,Intraperitoneal Infusions,Parenteral Infusions,Peritoneal Infusions,Infusion, Intra-Abdominal,Infusion, Intraperitoneal,Infusion, Parenteral,Infusion, Peritoneal,Infusions, Intra-Abdominal,Infusions, Intraperitoneal,Infusions, Peritoneal,Intra Abdominal Infusions,Intra-Abdominal Infusion,Intraperitoneal Infusion,Parenteral Infusion,Peritoneal Infusion
D008297 Male Males
D008787 Metoclopramide A dopamine D2 antagonist that is used as an antiemetic. 4-Amino-5-chloro-N-(2-(diethylamino)ethyl)-2-methoxybenzamide,Cerucal,Maxolon,Metaclopramide,Metoclopramide Dihydrochloride,Metoclopramide Hydrochloride,Metoclopramide Monohydrochloride,Metoclopramide Monohydrochloride, Monohydrate,Primperan,Reglan,Rimetin,Dihydrochloride, Metoclopramide,Hydrochloride, Metoclopramide,Monohydrochloride, Metoclopramide
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D002945 Cisplatin An inorganic and water-soluble platinum complex. After undergoing hydrolysis, it reacts with DNA to produce both intra and interstrand crosslinks. These crosslinks appear to impair replication and transcription of DNA. The cytotoxicity of cisplatin correlates with cellular arrest in the G2 phase of the cell cycle. Platinum Diamminodichloride,cis-Diamminedichloroplatinum(II),cis-Dichlorodiammineplatinum(II),Biocisplatinum,Dichlorodiammineplatinum,NSC-119875,Platidiam,Platino,Platinol,cis-Diamminedichloroplatinum,cis-Platinum,Diamminodichloride, Platinum,cis Diamminedichloroplatinum,cis Platinum
D003606 Dacarbazine An antineoplastic agent. It has significant activity against melanomas. (from Martindale, The Extra Pharmacopoeia, 31st ed, p564) DTIC,5-(3,3-Dimethyl-1-triazeno)imidazole-4-carboxamide,Biocarbazine,DIC,DTIC-Dome,Decarbazine,Deticene,Dimethyl Imidazole Carboxamide,Dimethyl Triazeno Imidazole Carboxamide,ICDT,NSC-45388,Carboxamide, Dimethyl Imidazole,DTIC Dome,DTICDome,Imidazole Carboxamide, Dimethyl,NSC 45388,NSC45388
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly

Related Publications

W A Agostinucci, and R H Gannon, and P K Schauer, and J K Walters
Combination metoclopramide and diphenhydramine short infusion for prevention of chemotherapy-induced emesis.
April 1990, American journal of clinical oncology,
W A Agostinucci, and R H Gannon, and P K Schauer, and J K Walters
Continuous infusion versus intermittent short infusion of metoclopramide for cisplatin-induced acute emesis.
October 1994, American journal of clinical oncology,
W A Agostinucci, and R H Gannon, and P K Schauer, and J K Walters
Continuous versus intermittent infusion of high-dose metoclopramide in prevention of cisplatin-induced emesis.
September 1992, Lancet (London, England),
W A Agostinucci, and R H Gannon, and P K Schauer, and J K Walters
Metoclopramide and chemotherapy-induced emesis.
July 1984, Annals of internal medicine,
W A Agostinucci, and R H Gannon, and P K Schauer, and J K Walters
Metoclopramide kinetics at high-dose infusion rates for prevention of cisplatin-induced emesis.
January 1985, Clinical pharmacology and therapeutics,
W A Agostinucci, and R H Gannon, and P K Schauer, and J K Walters
Continuous subcutaneous (CS) infusion of metoclopramide (MCP) using a plastic disposable infusor for the treatment of chemotherapy-induced emesis.
January 1988, Journal of pain and symptom management,
W A Agostinucci, and R H Gannon, and P K Schauer, and J K Walters
A randomized trial of high dose bolus metoclopramide versus low-dose continuous infusion metoclopramide in the prevention of cisplatin-induced emesis.
June 1987, American journal of clinical oncology,
W A Agostinucci, and R H Gannon, and P K Schauer, and J K Walters
Optimising antiemesis in cancer chemotherapy: efficacy of continuous versus intermittent infusion of high dose metoclopramide in emesis induced by cisplatin.
November 1986, British medical journal (Clinical research ed.),
W A Agostinucci, and R H Gannon, and P K Schauer, and J K Walters
Comparison of two different high doses of metoclopramide in the prevention of chemotherapy-induced emesis.
December 1989, The Netherlands journal of medicine,
W A Agostinucci, and R H Gannon, and P K Schauer, and J K Walters
[The effect of metoclopramide, dexamethasone and antihistamine in the prevention of PAC chemotherapy-induced emesis].
February 1988, Nihon Sanka Fujinka Gakkai zasshi,
Copied contents to your clipboard!